Chronic GVHD, an autoimmune disease that follows allogeneic hematopoietic-cell
transplantation, is characterized by infections and debilitating tissue injury leading to …

Chronic graft-versus-host disease (GVHD) is the leading cause of late, nonrelapse mortality
and disability in allogeneic hematopoietic cell transplantation recipients and a major …

Graft-versus-host disease (GVHD) is a complication of allogeneic bone marrow
transplantation whereby transplanted naive and marrow-derived T cells damage recipient …

Extracorporeal photopheresis (ECP) has been used for over 35 years in the treatment of
erythrodermic cutaneous T‐cell lymphoma (CTCL) and over 20 years for chronic and acute …

BACKGROUND. Accurate detection of graft-versus-host disease (GVHD) is a major
challenge in the management of patients undergoing hematopoietic stem cell …

Biology-based markers to confirm or aid in the diagnosis or prognosis of chronic graft-versus-
host disease (GVHD) after allogeneic hematopoietic cell transplantation or monitor its …

Allogeneic hematopoietic stem cell transplantation (allo-SCT) is potentially curative for a
number of hematologic conditions, both malignant and nonmalignant. However, its success …

Human graft-versus-host disease (GVHD) biology beyond 3 months after hematopoietic
stem cell transplantation (HSCT) is complex. The Applied Biomarker in Late Effects of …

Biomarkers are increasingly used for diagnosis and treatment of transplant-related
complications including the first biomarker-driven interventional trials of acute graft-versus …

We investigated the tear cytokine profiles in patients who underwent stem cell
transplantation (SCT) and attempted to evaluate whether tear cytokines are associated with …